Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal NETTER-1 study with targeted radioligand therapy Lutathera
WorldMEN (17th International Workshop on Multiple Endocrine Neoplasia and other Rare Endocrine Tumors)
Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive (JFHOD)
114ème Congrès Français d’Urologie
23rd European Congress of Endocrinology (ECE)
American Society of Clinical Oncology (ASCO) Annual Meeting
Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting
ESMO (European Society for Medical Oncology) Congress
34th Annual Congress of the European Association of Nuclear Medicine (EANM)
NANETS (North American Neuroendocrine Tumor Society) Symposium